Equities

Vivani Medical Inc

Vivani Medical Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.62
  • Today's Change-0.01 / -0.61%
  • Shares traded39.44k
  • 1 Year change+45.95%
  • Beta3.2740
Data delayed at least 15 minutes, as of Apr 30 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Vivani Medical, Inc. is a preclinical-stage biopharmaceutical company. The Company develops miniaturized and subdermal implants utilizing its NanoPortal technology to enable the delivery of a range of medicines to treat chronic diseases. It is engaged in the development of the Company’s lead programs NPM-115 and NPM-119, is a GLP-1 implant candidates for the treatment of chronic weight management and patients with type 2 diabetes, respectively. Its other pipeline product candidates include NPM-139, and OKV-119. It uses this platform technology to develop and commercialize drug implant candidates for the treatment of chronic disease and medication non-adherence. It operates through two segments: Biopharm Division and Neuromodulation Division. The Company’s implant technology, which it refers as NanoPortal, utilizes a space-efficient design that allows a miniaturized implant to provide many months of therapeutic delivery of potent molecules.

  • Revenue in USD (TTM)0.00
  • Net income in USD-25.65m
  • Incorporated2003
  • Employees44.00
  • Location
    Vivani Medical Inc1350 S. LOOP ROADALAMEDA 94502United StatesUSA
  • Phone+1 (818) 833-5000
  • Fax+1 (818) 833-5067
  • Websitehttp://www.secondsight.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
IR-MED Inc0.00-4.91m62.94m6.00--172.43-----0.0714-0.07140.000.00520.00----0.00-228.70---310.89--------------0.3061-------3.70------
Pro-Dex Inc48.24m5.00m64.61m146.0013.232.0510.691.341.391.3913.448.980.97462.303.68330,438.3010.1115.4312.9418.8728.2533.1510.3714.922.16--0.27530.009.6215.4654.7232.380.8422--
Asensus Surgical Inc8.58m-78.43m68.00m207.00--1.98--7.93-0.3162-0.31620.03440.12610.0981.702.9841,434.78-89.57-71.10-103.14-79.04-53.38-71.39-914.46-1,207.712.31--0.00--21.02-18.67-3.80---6.14--
Alpha Pro Tech, Ltd.61.23m4.19m69.69m124.0017.161.1313.631.140.35430.35435.165.390.91691.7211.25493,814.506.2715.216.5216.0637.2840.236.8412.9312.83--0.000.00-1.215.6027.642.935.50--
Monogram Orthopaedics Inc365.00k-13.75m71.09m28.00------194.76-0.4621-0.46210.0123--0.0241----13,035.71-90.82-119.26-149.39-257.400.00---3,765.81-5,045.60----0.00-------0.3964---15.97--
DIH Holding US Inc60.30m-1.77m72.58m--------1.20-0.0435-0.04351.49-0.8079----------------60.18---2.93--0.26561.50----12.15--80.41------
Vivani Medical Inc0.00-25.65m89.61m44.00--4.01-----0.5042-0.50420.000.40680.00----0.00-52.93-56.58-60.80-67.66-------2,868.72----0.00-------84.69--40.33--
Vuzix Corp12.13m-50.15m90.62m94.00--1.12--7.47-0.7893-0.78930.19121.250.1111.463.10129,033.50-45.91-41.61-50.66-44.80-21.72-6.13-413.46-317.286.23--0.00--2.488.42-23.02--39.42--
Myomo Inc19.24m-8.15m94.58m101.00--10.02--4.92-0.2726-0.27260.62650.33131.563.788.99190,506.40-65.86-81.78-104.03-115.2768.5168.50-42.34-85.762.16--0.00--23.7051.0924.00--2.82--
Envoy Medical Inc316.00k-29.91m96.24m34.00------304.54-2.60-2.600.0207-0.0899------9,294.12---------149.68---9,464.56--0.8169-266.25----33.33---87.83------
KORU Medical Systems Inc28.52m-13.74m101.93m82.00--5.00--3.57-0.3012-0.30120.62540.44570.80572.397.50347,776.50-38.82-17.60-46.28-20.2958.5959.44-48.18-21.703.77--0.0351--2.2310.44-58.65--11.10--
Neuronetics Inc71.35m-30.19m105.96m203.00--3.01--1.49-1.06-1.062.491.180.61322.094.86351,468.00-25.95-28.02-33.60-34.7375.1375.73-42.31-51.044.33-5.280.6342--9.426.2218.76--18.57--
Fonar Corp102.42m12.16m107.97m561.009.230.65895.191.051.741.7414.6024.420.512420.351.44182,570.608.338.738.649.6045.6748.3316.2516.399.15--0.0055--1.083.89-24.71-15.058.48--
TELA Bio Inc58.45m-46.66m111.44m227.00--5.86--1.91-2.06-2.062.560.77080.80131.477.15257,502.20-63.97-52.00-80.09-60.9568.6265.32-79.83-107.653.45-8.440.6821--41.1347.85-5.35---17.12--
Akso Health Group - ADR2.20m-17.07m114.81m12.00------52.12-0.7466-0.24610.0963--0.11661.910.3202183,560.00-89.84-17.36-224.28-23.997.56---770.59-256.641.36-24.020.6531--119.69-34.25-221.68------
Data as of Apr 30 2024. Currency figures normalised to Vivani Medical Inc's reporting currency: US Dollar USD

Institutional shareholders

6.11%Per cent of shares held by top holders
HolderShares% Held
Tanager Wealth Management LLPas of 31 Dec 20231.65m3.00%
The Vanguard Group, Inc.as of 31 Dec 2023452.10k0.82%
Commonwealth Equity Services LLCas of 31 Dec 2023360.53k0.66%
Monetary Management Group, Inc.as of 31 Dec 2023304.98k0.56%
Geode Capital Management LLCas of 31 Dec 2023197.14k0.36%
Glassman Wealth Services LLCas of 31 Dec 2023140.39k0.26%
Evoke Wealth LLCas of 31 Dec 2023134.87k0.25%
BlackRock Fund Advisorsas of 31 Dec 202353.78k0.10%
Northern Trust Investments, Inc.(Investment Management)as of 31 Dec 202335.19k0.06%
Charles Schwab Investment Management, Inc.as of 31 Dec 202330.02k0.06%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.